Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03213275 |
Date of registration:
|
05/07/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
The Premature Gut Microbiome and the Influence on Neonatal Immunity, Brain Development and White Matter Injury
PreMiBraIn |
Scientific title:
|
The Premature Gut Microbiome and the Influence on Neonatal Immunity, Brain Development and White Matter Injury |
Date of first enrolment:
|
October 11, 2017 |
Target sample size:
|
60 |
Recruitment status: |
Active, not recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03213275 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Austria
| | | | | | | |
Contacts
|
Name:
|
Lukas Wisgrill, M.D. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Medical University of Vienna |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Gestational age < 28+0 weeks
- Birth weight < 1000 gram
Exclusion Criteria:
- chromosomal aberrations
- congenital malformations
- inborn metabolic disorders
- maternal chronic infectious diseases
- missing informed consent
Age minimum:
N/A
Age maximum:
2 Days
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Neurodevelopment Outcome
|
Immunology
|
Microbiome
|
Intervention(s)
|
Other: Microbiome Sequencing, Neurophysiologic Assessment, Immunological test
|
Primary Outcome(s)
|
Neurodevelopmental outcome with corrected age of two and five years
[Time Frame: Eight Years]
|
Secondary ID(s)
|
PreMiBraIn
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|